SIRT1: a potential tumour biomarker and therapeutic target

Bin Zhao(Guangzhou Women and Children Medical Center), Peng Shang(Tibet University), Xin Li(Huazhong University of Science and Technology), Ye Wang(Northwestern Polytechnical University), Liangfu Zhou(Fudan University)
Journal of drug targeting
May 6, 2019
10.1080/1061186x.2019.1605519
Cited by 33

Related Papers

Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
|Cancer Letters|2020|586
Advances on Bioactive Polysaccharides from Medicinal Plants
|Critical Reviews in Food Science and Nutrition|2015|560
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
|PubMed|2018|374
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355